{"id":"https://openalex.org/W3010816592","doi":"https://doi.org/10.1099/jmm.0.001177","title":"A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections","display_name":"A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections","publication_year":2020,"publication_date":"2020-03-20","ids":{"openalex":"https://openalex.org/W3010816592","doi":"https://doi.org/10.1099/jmm.0.001177","mag":"3010816592","pmid":"https://pubmed.ncbi.nlm.nih.gov/32195649"},"language":"en","primary_location":{"id":"doi:10.1099/jmm.0.001177","doi":"https://doi.org/10.1099/jmm.0.001177","is_oa":false,"landing_page_url":"https://doi.org/10.1099/jmm.0.001177","pdf_url":null,"source":{"id":"https://openalex.org/S154078021","display_name":"Journal of Medical Microbiology","issn_l":"0022-2615","issn":["0022-2615","1473-5644"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320497","host_organization_name":"Microbiology Society","host_organization_lineage":["https://openalex.org/P4310320497"],"host_organization_lineage_names":["Microbiology Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://eprints.whiterose.ac.uk/id/eprint/159233/9/Revised%20Wound%20Infection%20Manuscript_18feb2020.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004741643","display_name":"Stephanie Noviello","orcid":"https://orcid.org/0000-0001-5555-9328","observed_orcids":["https://orcid.org/0000-0001-5555-9328"]},"institutions":[{"id":"https://openalex.org/I4210140002","display_name":"Motif BioSciences (United States)","ror":"https://ror.org/04815fk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140002"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Noviello","raw_affiliation_strings":["Motif BioSciences, Princeton, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0001-5555-9328","affiliations":[{"raw_affiliation_string":"Motif BioSciences, Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210140002"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062306774","display_name":"G. Ralph Corey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Ralph Corey","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057825659","display_name":"Thomas L Holland","orcid":"https://orcid.org/0000-0001-7745-9010","observed_orcids":["https://orcid.org/0000-0001-7745-9010"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas L. Holland","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0001-7745-9010","affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084249121","display_name":"Thomas P. Lodise","orcid":"https://orcid.org/0000-0002-4730-0655","observed_orcids":["https://orcid.org/0000-0002-4730-0655"]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Lodise","raw_affiliation_strings":["Albany College of Pharmacy and Health Sciences, Albany, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany College of Pharmacy and Health Sciences, Albany, New York","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110473005","display_name":"William D. O\u2019Riordan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William O\u2019Riordan","raw_affiliation_strings":["eStudySite, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eStudySite, San Diego, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027928189","display_name":"Mark H. Wilcox","orcid":"https://orcid.org/0000-0002-4565-2868","observed_orcids":["https://orcid.org/0000-0002-4565-2868"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]},{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark H. Wilcox","raw_affiliation_strings":["Leeds Teaching Hospitals & University of Leeds, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Teaching Hospitals & University of Leeds, Leeds, UK","institution_ids":["https://openalex.org/I130828816","https://openalex.org/I2799390153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113451778","display_name":"Thomas M. File","orcid":"https://orcid.org/0009-0009-6080-467X","observed_orcids":["https://orcid.org/0009-0009-6080-467X"]},"institutions":[{"id":"https://openalex.org/I1294639003","display_name":"Summa Health System","ror":"https://ror.org/03p6fpw74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1294639003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M. File","raw_affiliation_strings":["Summa Health, Akron, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Summa Health, Akron, Ohio, USA","institution_ids":["https://openalex.org/I1294639003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010679786","display_name":"Matthew Dryden","orcid":"https://orcid.org/0000-0002-8967-169X","observed_orcids":["https://orcid.org/0000-0002-8967-169X"]},"institutions":[{"id":"https://openalex.org/I2802891629","display_name":"Royal Hampshire County Hospital","ror":"https://ror.org/00hhwej14","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802891629","https://openalex.org/I312843336"]},{"id":"https://openalex.org/I312843336","display_name":"Hampshire Hospitals NHS Foundation Trust","ror":"https://ror.org/04shzs249","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I312843336"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew Dryden","raw_affiliation_strings":["Department of Microbiology and Infection, Hampshire Hospitals NHS Foundation Trust, Winchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Infection, Hampshire Hospitals NHS Foundation Trust, Winchester, UK","institution_ids":["https://openalex.org/I2802891629","https://openalex.org/I312843336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080852167","display_name":"Barbara Balser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267304","display_name":"Veristat, LLC (United States)","ror":"https://ror.org/023qnpq80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267304"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Balser","raw_affiliation_strings":["Veristat, Southborough, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veristat, Southborough, Massachusetts, USA","institution_ids":["https://openalex.org/I4405267304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074573989","display_name":"Amy Scaramucci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267304","display_name":"Veristat, LLC (United States)","ror":"https://ror.org/023qnpq80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267304"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Scaramucci","raw_affiliation_strings":["Veristat, Southborough, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veristat, Southborough, Massachusetts, USA","institution_ids":["https://openalex.org/I4405267304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100752902","display_name":"Anton\u00ed Torres","orcid":"https://orcid.org/0000-0002-8643-2167","observed_orcids":["https://orcid.org/0000-0002-8643-2167","https://orcid.org/0000-0002-5470-2978"]},"institutions":[{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antoni Torres","raw_affiliation_strings":["Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D'investigacions August Pi I Sunyer, Centro de Investigaci\u00f3n Biomedica En Red-Enfermedades Respiratorias, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D'investigacions August Pi I Sunyer, Centro de Investigaci\u00f3n Biomedica En Red-Enfermedades Respiratorias, Barcelona, Spain","institution_ids":["https://openalex.org/I4210099160","https://openalex.org/I4210115097","https://openalex.org/I71999127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016570350","display_name":"David B. Huang","orcid":"https://orcid.org/0000-0001-8228-7911","observed_orcids":["https://orcid.org/0000-0001-8228-7911","https://orcid.org/0000-0002-8342-3193"]},"institutions":[{"id":"https://openalex.org/I4210140002","display_name":"Motif BioSciences (United States)","ror":"https://ror.org/04815fk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140002"]},{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David B. Huang","raw_affiliation_strings":["Motif BioSciences, Princeton, New Jersey, USA","Rutgers New Jersey Medical School, Trenton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Motif BioSciences, Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210140002"]},{"raw_affiliation_string":"Rutgers New Jersey Medical School, Trenton, New Jersey, USA","institution_ids":["https://openalex.org/I4402554120"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0983,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.5690529,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"69","issue":"4","first_page":"625","last_page":"630"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.06689999997615814,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":0.05480000004172325,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iclaprim","display_name":"iclaprim","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/acute-bacterial-skin-and-skin-structure-infections","display_name":"acute bacterial skin and skin structure infections","score":0.9869999885559082},{"id":"https://openalex.org/keywords/wound-infection","display_name":"wound infection","score":0.9760000109672546},{"id":"https://openalex.org/keywords/gram-positive-pathogens","display_name":"Gram-positive pathogens","score":0.6380000114440918},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8450000286102295},{"id":"https://openalex.org/keywords/early-clinical-response","display_name":"early clinical response","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lesion-size-reduction","display_name":"lesion size reduction","score":0.875},{"id":"https://openalex.org/keywords/antibiotic-safety","display_name":"antibiotic safety","score":0.6389999985694885},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.7570000290870667},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.953000009059906},{"id":"https://openalex.org/keywords/pooled-analysis","display_name":"pooled analysis","score":0.6990000009536743},{"id":"https://openalex.org/keywords/intravenous-antibiotics","display_name":"intravenous antibiotics","score":0.6039999723434448},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8254646062850952},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.7781293392181396},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6088228225708008},{"id":"https://openalex.org/C2777052132","wikidata":"https://www.wikidata.org/wiki/Q595158","display_name":"Methicillin-resistant Staphylococcus aureus","level":4,"score":0.49442052841186523},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4521713852882385},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.43831273913383484},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42505067586898804},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4097696542739868},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.13808602094650269},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0799981951713562},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.05566874146461487},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014946","descriptor_name":"Wound Infection","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014946","descriptor_name":"Wound Infection","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D017192","descriptor_name":"Skin Diseases, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017192","descriptor_name":"Skin Diseases, Bacterial","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1099/jmm.0.001177","doi":"https://doi.org/10.1099/jmm.0.001177","is_oa":false,"landing_page_url":"https://doi.org/10.1099/jmm.0.001177","pdf_url":null,"source":{"id":"https://openalex.org/S154078021","display_name":"Journal of Medical Microbiology","issn_l":"0022-2615","issn":["0022-2615","1473-5644"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320497","host_organization_name":"Microbiology Society","host_organization_lineage":["https://openalex.org/P4310320497"],"host_organization_lineage_names":["Microbiology Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Microbiology","raw_type":"journal-article"},{"id":"pmid:32195649","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32195649","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical microbiology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:eprints.whiterose.ac.uk:159233","doi":null,"is_oa":true,"landing_page_url":"https://eprints.whiterose.ac.uk/id/eprint/159233/9/Revised%20Wound%20Infection%20Manuscript_18feb2020.pdf","pdf_url":"https://eprints.whiterose.ac.uk/id/eprint/159233/9/Revised%20Wound%20Infection%20Manuscript_18feb2020.pdf","source":{"id":"https://openalex.org/S4306400854","display_name":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800616092","host_organization_name":"White Rose University Consortium","host_organization_lineage":["https://openalex.org/I2800616092"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:eprints.whiterose.ac.uk:159233","doi":null,"is_oa":true,"landing_page_url":"https://eprints.whiterose.ac.uk/id/eprint/159233/9/Revised%20Wound%20Infection%20Manuscript_18feb2020.pdf","pdf_url":"https://eprints.whiterose.ac.uk/id/eprint/159233/9/Revised%20Wound%20Infection%20Manuscript_18feb2020.pdf","source":{"id":"https://openalex.org/S4306400854","display_name":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800616092","host_organization_name":"White Rose University Consortium","host_organization_lineage":["https://openalex.org/I2800616092"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320310096","display_name":"Alere","ror":"https://ror.org/01zt0tq34"},{"id":"https://openalex.org/F4320315426","display_name":"BioCryst","ror":"https://ror.org/031mgj447"},{"id":"https://openalex.org/F4320315666","display_name":"Medicines Company","ror":null},{"id":"https://openalex.org/F4320318446","display_name":"European Tissue Symposium","ror":"https://ror.org/022bzxa10"},{"id":"https://openalex.org/F4320318975","display_name":"Nabriva Therapeutics","ror":"https://ror.org/017ax4r20"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320330226","display_name":"Da Volterra","ror":"https://ror.org/02zyqwj39"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3010816592.pdf","grobid_xml":"https://content.openalex.org/works/W3010816592.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2003788939","https://openalex.org/W2062990040","https://openalex.org/W2083105180","https://openalex.org/W2106330783","https://openalex.org/W2106793787","https://openalex.org/W2119542781","https://openalex.org/W2134443476","https://openalex.org/W2752397167","https://openalex.org/W2778606863","https://openalex.org/W2789912955","https://openalex.org/W2804406807"],"related_works":["https://openalex.org/W2896658653","https://openalex.org/W2804406807","https://openalex.org/W2752713307","https://openalex.org/W2778606863","https://openalex.org/W2789912955","https://openalex.org/W2940825000","https://openalex.org/W4295935779","https://openalex.org/W2981961965","https://openalex.org/W2799714015","https://openalex.org/W2158190550"],"abstract_inverted_index":{"Introduction.":[0],"Iclaprim":[1,256],"is":[2],"a":[3,57,96,183,206,239,259],"diaminopyrimidine":[4],"antibiotic":[5],"for":[6,76,205,263],"the":[7,162],"treatment":[8,184,261],"of":[9,35,61,186,209],"acute":[10],"bacterial":[11],"skin":[12,14],"and":[13,201,218],"structure":[15],"infections":[16,29,42,247],"(ABSSSI)":[17],"due":[18],"to":[19,83,92,236],"Gram-positive":[20,254],"pathogens.":[21,255],"Aim.":[22],"This":[23],"analysis":[24,60],"evaluates":[25],"patients":[26,39,176,244],"with":[27,40,66,125,130,146,151,171,182,211,215,220,224,238,245],"wound":[28,41,174,246,264],"from":[30,43,100],"two":[31,44],"Phase":[32,45],"3":[33],"trials":[34,52],"ABSSSI.":[36],"Methodology.":[37],"Six-hundred-two":[38],"3,":[46],"double-blinded,":[47],"randomized,":[48],"multicenter,":[49],"active":[50],"controlled":[51],"(REVIVE-1/\u20132)":[53],"were":[54],"evaluated":[55],"in":[56,94,102,199,243],"post":[58],"hoc":[59],"iclaprim":[62,86,126,147,165,216,221,233],"80":[63],"mg":[64,69],"compared":[65,170,214,223],"vancomycin":[67,93,131,152,172,212,225,237],"15":[68],"kg\u20131":[70],"administered":[71],"intravenously":[72],"every":[73],"12":[74],"h":[75,106],"5\u201314":[77],"days.":[78],"The":[79,194],"primary":[80],"endpoint":[81],"was":[82,87,116,122,143,197],"determine":[84],"whether":[85],"non-inferior":[88],"(10":[89],"%":[90,98,124,129,136,145,150,157,178,188,190],"margin)":[91],"achieving":[95],"\u226520":[97],"reduction":[99],"baseline":[101],"lesion":[103],"size":[104],"48\u201372":[105],"after":[107],"starting":[108],"study":[109],"drug":[110],"(early":[111],"clinical":[112,231],"response":[113],"[ECR]).":[114],"Safety":[115],"assessed.":[117],"Results.":[118],"In":[119,140,161],"REVIVE-1,":[120],"ECR":[121,142,168],"83.5":[123],"versus":[127,148],"79.7":[128],"(treatment":[132,153],"difference":[133,154,185],"3.77%,":[134],"95":[135,156],"CI":[137,158,191],"\u22124.50%,":[138],"12.04%).":[139],"REVIVE-2,":[141],"82.7":[144],"76.3":[149],"6.38%,":[155],"\u22123.35%,":[159],"16.12%).":[160],"pooled":[163],"dataset,":[164],"had":[166],"similar":[167,198,240],"rates":[169],"among":[173],"infection":[175],"(83.2":[177],"vs":[179],"78.2":[180],"%)":[181],"5.01":[187],"(95":[189],"\u22121.29%,":[192],"11.32%).":[193],"safety":[195,241],"profile":[196,242],"iclaprim-":[200],"vancomycin-treated":[202],"patients,":[203],"except":[204],"higher":[207],"incidence":[208],"diarrhea":[210],"(n=17)":[213,222],"(n=6)":[217],"fatigue":[219],"(n=8).":[226],"Conclusion.":[227],"Based":[228],"on":[229],"early":[230],"response,":[232],"achieved":[234],"non-inferiority":[235],"suspected":[248],"or":[249],"confirmed":[250],"as":[251],"caused":[252],"by":[253],"may":[257],"be":[258],"valuable":[260],"option":[262],"infections.":[265]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-03-23T00:00:00"}